Abstract
BPH treatment has relative response to alpha-1 blockers and 5-alpha reductase inhibitors (25-39%). In spite of these treatments, many patients complain of nocturia. Desmopressin and celecoxib have been used in BPH for treatment of nocturia, but there are no studies that compare the effectiveness of these two drugs for nocturia.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
